Employer Active
Job Alert
You will be updated with latest job alerts via emailJob Alert
You will be updated with latest job alerts via emailThe laboratory of Angiogenesis and Vascular Metabolism headed by Peter Carmeliet is one of the laboratories of the Center for Cancer Biology (CCB), a research department of VIB (Flanders Institute for Biotechnology) located in the Oncology Faculty at the KU Leuven (Campus Gasthuisberg, Leuven, Belgium). The lab of Prof Carmeliet has open positions for Laboratory Technicians. The Department employs more than 200 scientists and covers a range of different research areas in The infrastructure at CCB is well developed with modern laboratories, core and animal
The Laboratory of Angiogenesis and Vascular Metabolism headed by Peter Carmeliet focuses on the development of blood vessels (angiogenesis) and vascular heterogeneity in health and disease, with the aim to identify novel therapeutic pro-and anti-angiogenic strategies ().
Current anti-angiogenesis therapies (AATs), by targeting the pro-angiogenic factor VEGF, suffer resistance and insufficient The Carmeliet lab explores opportunities to overcome these limitations and to improve AAT by focusing on endothelial cell metabolism, endothelial heterogeneity and in particular, endothelial Recent projects, combining single-cell transcriptomics with bulk multi-omics (transcriptomics, (epi)-genomics, proteomics & metabolomics) revealed novel insights into endothelial cell metabolism and heterogeneity in health and disease that can help design novel AAT See below for more project
The lab is looking for a motivated Laboratory Technician to help us to discover new therapeutic targets (using bulk/single-cell multi-omics) and bridge the valley of death (by functionally validating these targets). As part of our translational research team, you will join a dynamic and experienced team of laboratory We are looking for dynamic and flexible candidates, willing to step into new adventures, daring to break new grounds outside of their comfort zone, passionate about opportunities to set up new technologies and facilities, not being shy of diving into new fields, being primed and eager to become acquainted with new
Key Accountabilities:
The Carmeliet lab applies its expertise and research focus to evaluate and deliver novel therapeutic concepts into clinical development with the ambition to change the life of patients with vasculature-related Standard gene modulation strategies (conditional gene targeting/silencing/overexpression) are exploited as well as novel, sophisticated, high-throughput multi-omics approaches (bulk and scRNAseq, scG&T, scATAC, ) and computational modelling and biology (artificial intelligence, machine learning), both for hypothesis-generating and hypothesis-testing For instance, recent successful efforts in generating a single-cell transcriptome atlas of endothelial cells (ECs) from various healthy and pathological (including tumor) tissues from preclinical models and clinical patient samples have revealed the existence of previously unknown endothelial cell subtypes, including endothelial cells with a resident endothelial stem cell signature, and endothelial cells with a putative immune-modulatory role (termed IMECs ), key findings being taken into further In addition, we developed an innovative AI-based tool to predict novel unknown genes in ECs, and to develop alternative
A major challenge of current medical research is to translate the obtained high-profile insights into new We aspire to not only discover new therapeutic targets but also to "bridge the valley of death" in order to improve drug
Applications for this position should be submitted If you have questions about this position, please contact Peter Carmeliet: or Katie Van Geyte: .
Full Time